Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho

Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully...

Full description

Bibliographic Details
Main Authors: Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661823003651
_version_ 1797422659083960320
author Min Liu
Yang Zhang
Ping Zhan
Wenjuan Sun
Chuanqiao Dong
Xiaohan Liu
Yujie Yang
Xiaojie Wang
Yusheng Xie
Chengjiang Gao
Huili Hu
Benkang Shi
Ziying Wang
Chun Guo
Fan Yi
author_facet Min Liu
Yang Zhang
Ping Zhan
Wenjuan Sun
Chuanqiao Dong
Xiaohan Liu
Yujie Yang
Xiaojie Wang
Yusheng Xie
Chengjiang Gao
Huili Hu
Benkang Shi
Ziying Wang
Chun Guo
Fan Yi
author_sort Min Liu
collection DOAJ
description Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully understood. The present study was mainly designed to investigate the role of HDACs in renal injury induced by hHcys. Firstly, we identified the expression patterns of HDACs and found that, among zinc-dependent HDACs, HDAC9 was preferentially upregulated in the kidney from mice with hHcys. Deficiency or pharmacological inhibition of HDAC9 ameliorated renal injury in mice with hHcys. Moreover, podocyte-specific deletion of HDAC9 significantly attenuated podocyte injury and proteinuria. In vitro, gene silencing of HDAC9 attenuated podocyte injury by inhibiting apoptosis, reducing oxidative stress and maintaining the expressions of podocyte slit diaphragm proteins. Mechanically, we proved for the first time that HDAC9 reduced the acetylation level of H3K9 in the promoter of Klotho, then inhibited gene transcription of Klotho, finally aggravating podocyte injury in hHcys. In conclusion, our results indicated that targeting of HDAC9 might be an attractive therapeutic strategy for the treatment of renal injury induced by hHcys.
first_indexed 2024-03-09T07:36:33Z
format Article
id doaj.art-b75d1c61ff964de882682ddef23b59b2
institution Directory Open Access Journal
issn 1096-1186
language English
last_indexed 2024-03-09T07:36:33Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj.art-b75d1c61ff964de882682ddef23b59b22023-12-03T05:39:43ZengElsevierPharmacological Research1096-11862023-12-01198107009Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of KlothoMin Liu0Yang Zhang1Ping Zhan2Wenjuan Sun3Chuanqiao Dong4Xiaohan Liu5Yujie Yang6Xiaojie Wang7Yusheng Xie8Chengjiang Gao9Huili Hu10Benkang Shi11Ziying Wang12Chun Guo13Fan Yi14Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Obstetrics, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaThe Key Laboratory of Infection and Immunity of Shandong Province, Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaThe Key Laboratory of Experimental Teratology, Ministry of Education, Department of Molecular Medicine and Genetics, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Corresponding authors.School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Corresponding authors.Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Corresponding authors.Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully understood. The present study was mainly designed to investigate the role of HDACs in renal injury induced by hHcys. Firstly, we identified the expression patterns of HDACs and found that, among zinc-dependent HDACs, HDAC9 was preferentially upregulated in the kidney from mice with hHcys. Deficiency or pharmacological inhibition of HDAC9 ameliorated renal injury in mice with hHcys. Moreover, podocyte-specific deletion of HDAC9 significantly attenuated podocyte injury and proteinuria. In vitro, gene silencing of HDAC9 attenuated podocyte injury by inhibiting apoptosis, reducing oxidative stress and maintaining the expressions of podocyte slit diaphragm proteins. Mechanically, we proved for the first time that HDAC9 reduced the acetylation level of H3K9 in the promoter of Klotho, then inhibited gene transcription of Klotho, finally aggravating podocyte injury in hHcys. In conclusion, our results indicated that targeting of HDAC9 might be an attractive therapeutic strategy for the treatment of renal injury induced by hHcys.http://www.sciencedirect.com/science/article/pii/S1043661823003651HDAC9EpigeneticKlothoPodocyteHyperhomocysteinemia
spellingShingle Min Liu
Yang Zhang
Ping Zhan
Wenjuan Sun
Chuanqiao Dong
Xiaohan Liu
Yujie Yang
Xiaojie Wang
Yusheng Xie
Chengjiang Gao
Huili Hu
Benkang Shi
Ziying Wang
Chun Guo
Fan Yi
Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
Pharmacological Research
HDAC9
Epigenetic
Klotho
Podocyte
Hyperhomocysteinemia
title Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
title_full Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
title_fullStr Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
title_full_unstemmed Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
title_short Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
title_sort histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of klotho
topic HDAC9
Epigenetic
Klotho
Podocyte
Hyperhomocysteinemia
url http://www.sciencedirect.com/science/article/pii/S1043661823003651
work_keys_str_mv AT minliu histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT yangzhang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT pingzhan histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT wenjuansun histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT chuanqiaodong histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT xiaohanliu histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT yujieyang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT xiaojiewang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT yushengxie histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT chengjianggao histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT huilihu histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT benkangshi histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT ziyingwang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT chunguo histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho
AT fanyi histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho